Allele Biotechnology: Allele Biotech's cGMP iPSCs Used as Packaging Factories for Dual COVID Vaccine

(marketscreener.com) Allele Biotechnology and Pharmaceuticals, Inc. has been using mRNA as its core technology for creating cGMP-grade iPSC lines for regenerative medicine and oncology for over a decade. At the onset of the COVID-19 pandemic, Allele had to pause ongoing therapeutic programs developing iPSC derived pancreatic beta cells, neuroprogenitor cells, lung...https://www.marketscreener.com/news/latest/Allele-Biotech-s-cGMP-iPSCs-Used-as-Packaging-Factories-for-Dual-COVID-Vaccine--31462489/?utm_medium=RSS&utm_content=20201002